This Kalorama Information report , The World Market for Diabetes Treatments, provides market estimates and forecasts for the world market for diabetes treatments. The diabetes market is one of the fastest growing markets within the pharmaceutical sector, and is one of the few pharmaceutical sectors that are likely to continue to grow at double digit rates throughout the forecast period. Major contributing factors to growth are increasing obesity and an aging worldwide population. The total market for diabetes treatments is divided into two major segments:
The report’s geographic scope is worldwide with information for specific geographical regions; world demographics; life expectancy by country, and other general issues affecting the market. Trends covered in the report include:
A market summary includes market analysis by product and region and a competitive analysis of leading providers. Additionally, key company profiles are included, including profiles of the following:
For the purpose of this study, Kalorama Information conducted interviews with more than 25 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.
All market data pertains to the world market at the manufacturers’ level. The base year for data was 2009. Historical data was provided for the years 2008, with forecast data provided for 2010 through 2015. Compound annual growth rates (CAGRs) are provided for 2008-2015 periods for each region and/or segment covered. Competitive analysis is provided for the year 2009. The forecasted market analysis for 2009-2015 was largely based on demographic trends, new developments, innovative technology and global expansion.
"Safe Bet" Diabetes Market Spurs Competition and New Products
The diabetes market is one of the fastest growing areas within the pharmaceutical sector, one of the few areas that is likely to continue to grow at double digit rates, according to healthcare market research publisher Kalorama Information. The promise of a near-certain market for patients has lead to competition among top names in pharmaceuticals to try to secure a position in the market with a new product, according to The World Market for Diabetes Treatments.
Diabetes is typically treated using diet control, exercise, and the monitoring of blood glucose several times a day. In some cases oral medication and/or insulin is prescribed, especially where diet or exercise is not enough, creating opportunity for drug makers. According to the report, the total diabetes therapeutic market reached $24.9 billion in 2009, increasing 16.4% from the previous year. This level of growth is expected to continue at least for the next two years, according to Kalorama Information. Major contributing factors to growth are increasing obesity and an aging worldwide population.
"Diabetes is seen as kind of a 'safe bet' development area as pharmacos try to carve out a piece of this income stream with a treatment that is a bit more effective," said Bruce Carlson, Publisher of Kalorama Information. "Unfortunately there has been little or no improvement in the numbers through diet and exercise. Even if there were improvement, there would still be a large pool of existing patients requiring treatment."
Top companies in the market include NovoNordisk, Sanofi-Aventis, GlaxoSmithKline, Merck and Takeda. Kalorama’s report lists over 100 new diabetes products in the development pipeline by these firms and others. While the entire market is considered safer for investment than other pharmaceutical markets, individual product success is never guaranteed; products will succeed or fail, depending on their effectiveness, marketing, and how well they fit with medical practice.
The report, The World Market for Diabetes Treatments, contains more information on epidemiology, products, companies operating in the market, forecasts and market estimates.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook